Indiana life sciences companies rethink innovation
Research and development comes under pressure in an age of austerity.
Health Care & Life Sciences
Articles
WellPoint shares sink after profit misses analyst estimates
WellPoint Inc. stock fell more than 12 percent Wednesday after the insurer’s quarterly earnings missed analyst estimates and it trimmed its full-year forecast.
Lilly’s quarterly profit falls, but tops analyst expectations
Eli Lilly and Co. reported second-quarter profit that fell less than analysts had expected. The company raised its outlook for the rest of the year.
Potential Alzheimer’s drug fails first of four key trials
Bapineuzumab is in a race with a similar product from Indianapolis-based Eli Lilly and Co. to become the first therapy to target a cause for Alzheimer’s, rather than just its symptoms.
Survey: Solo practices nearly gone
Only 1 percent of the jobs given to Texas-based Merritt Hawkins over the past year were for solo practitioners, the physician recruiting firm reported this month. That’s down from 22 percent of all searches in 2004.
Suburban hospitals charm patients
A little extra Medicare money will flow to suburban hospitals in the Indianapolis area, based on recent patient satisfaction scores. But hospitals in the core of Indianapolis—and hospitals that do significant amounts of teaching medical students—may take a hit.
Positron moving $65M project from Noblesville to Gary
A troubled central Indiana nuclear medicine company is dropping plans to build a multimillion-dollar facility in Noblesville after reaching a better deal with the city of Gary.
Insurance company key to Franciscan-American Health partnership
Hospital system’s health insurance unit has IT infrastructure that will allow physicians to participate in Medicare’s shared savings program.
Westfield health IT firm sold for $473 million
MaxIT’s 1,300 employees, who provide information technology services to hospitals and physician practices, will join Virginia-based Science Applications International Corp.
Daniels looks to successors on health exchange
Gov. Mitch Daniels says he plans to ask his potential successors whether the state should set up a health care exchange.
IU Health makes prestigious Honor Roll list
For the first time, Indiana University Health has been named to U.S. News & World Report's "Best Hospitals Honor Roll," a distinction that goes to the top medical centers in the country.
Reform may hit hospitals harder
The immediate reaction on Wall Street to last month’s U.S. Supreme Court ruling upholding President Obama’s health care law was to buy hospital stocks and dump health insurance stocks. But at least one analyst expects the long-term outcome to be the exact opposite.
Lilly gets boost in Alzheimer’s race
Eli Lilly and Co. got a boost of confidence last week that its project to launch the first effective Alzheimer’s treatment is on the right track—though it still faces hugely long odds.
New IU public health schools reach milestone
Indiana University says an accrediting agency has approved its request to begin the accreditation process for the Schools of Public Health proposed for its Bloomington and Indianapolis campuses.
WellPoint using deals to prep for new era in insurance
The buying spree is back on at WellPoint Inc., with a twist. A decade ago, the insurer consolidated Blue Cross and Blue Shield plans that catered to employers. Today, it is making deals to grow the non-employer part of its business.
WellPoint agrees to pay for 3 children to get gene test
WellPoint Inc. said it will pay for DNA testing for three children to see if they have an inherited heart disease their father suffers from that often strikes without warning, reversing an earlier decision to deny coverage.
Potential Lilly antipsychotic falls short in study
Eli Lilly and Co. said a potential treatment for acute schizophrenia failed in a late-stage study that compared patients taking the drug to those taking a placebo.
Competing Alzheimer’s treatments facing long odds
Johnson & Johnson, Pfizer Inc. and Elan Corp are racing Indianapolis-based Eli Lilly and Co. to market the first broadly available drug designed to target a cause of Alzheimer’s, rather than just its symptoms. Analysts say the potential drugs are long shots.
Zoeller goes after closed Allcare Dental chain
A chain of dental offices that abruptly closed multiple Indiana locations in December 2010 left patients without care, refunds or records, according to a complaint filed by the Office of the Indiana Attorney General.
Local providers join Medicare ACO program
Indiana University Health, as well as a partnership of Franciscan Alliance and American Health Network, have formed accountable care organizations that won the blessing of the federal Medicare Shared Savings program.